Recombinant tissue type plasminogen activator treatment of thrombosed mitral valve prosthesis during pregnancy

Canadian Journal of Anaesthesia

Volumn 44, Issue 7, 1997, Pages 735-738

  Fleyfel, M ^a,b   Bourzoufi, K ^a   Huin, G ^a   Subtil, D ^a   Puech, F ^a  

^a LILLE UNIVERSITY HOSPITAL   (France)

^b UNIV LILLE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALTEPLASE;

ADULT; ARTICLE; CARDIOGENIC SHOCK; CARDIOPULMONARY BYPASS; CASE REPORT; DRUG EFFICACY; DRUG SAFETY; FEMALE; FIBRINOLYTIC THERAPY; HEART VALVE PROSTHESIS; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MITRAL VALVE PROSTHESIS; PREGNANCY; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION; THROMBOSIS;

EID: 0030691878     PISSN: 0832610X     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03013388     Document Type: Article

References (29)

1. Draur RA. Successful streptokinase therapy of prosthetic aortic valve thrombosis. Am Heart J 1984; 108: 605-6.
2. Salazar E, Zajarias A, Gutierrez N, Iturbe I. The problem of cardiac valve prostheses, anticoagulants and pregnancy. Circulation 1984; 70(Suppl 1): I-169-77.
3. Kontos GJ Jr, Schaff HV. Thrombotic occlusion of a prosthetic heart valve: diagnosis and management. Mayo Clin Proc 1985; 60: 118-22.
4. Pechet L, Alexander B. Increased clotting factors in pregnancy. N Engl J Med 1961; 265: 1093-6.
5. Laros RK Jr, Alger LS. Thromboembolism and pregnancy. Clin Obstet Gynecol 1979; 22: 871-86.
6. Tischler M, Lee RT, Kirshenbaum JM. Successful treatment of prosthetic tricuspid valve thrombosis with short-course recombinant tissue-type plasminogen activator. Am Heart J 1990; 120: 975-7.
7. Cohen ML, Barzilai B, Gutierrez F, Jaffe AS, Eisenberg P. Treatment of prosthetic tricuspid valve thrombosis wuth low-dose tissue plasminogen activator. Am Heart J 1990; 120: 978-80.
8. Ben Iamail M, Abid F, Trabelsi S,Taktak A, Fekih M. Cardiac valve prostheses, anticoagulation and pregnancy. Br Heart J 1986; 55: 101-5.
9. Mustapha R, Philip I, Bohm G, et al. Thromboses of heart valve prostheses: predisposing and prognostic factors based on a study of 41 patients. (French) Annales Chirurgie Thoracique et Cardio-vasculaire 1994; 48: 243-7.
10. Jost CMT, Yancy CW Jr, Ring WS. Combined thrombolytic therapy for prosthetic mitral valve thrombosis. Ann Thorac Surg 1993; 55: 159-61.
11. Deviri E, Sareli P, Wisenbaugh T, Cronje S. Obstruction of mechanical heart valve prostheses: clinical aspects and surgical management. J Am Coll Cardiol 1991; 17: 646-50.
12. Antunes MJ, Myer IG, Santos LP. Thrombosis of mitral valve prosthesis in pregnancy: management by simultaneous Caesarean section and mitral valve replacement. Case report. Br J Obstet Gynaecol 1984; 91: 716-8.
13. Vongpatanasin W, Hillis LD, Lange RA. Prosthetic heart valves. N Engl J Med 1996; 335: 407-16.
14. Habib G, Cornen A, Mesana T, Monties R, Dijane P, Luccioni R. Diagnosis of prosthetic heart valve thrombosis. The respective values of transthoracic and transoesophageal Doppler echocardiography. Eur Heart J 1993; 14: 447-55.
15. Gueret P, Vignon P, Fournier P, et al. Transesophageal echocardiography for the diagnosis and management of nonobstructive thrombosis of mechanical mitral valve prosthesis. Circulation 1995; 91: 103-10.
16. Young E, Shapiro SM, French WJ, Ginzton LE. Use of transesophageal echocardiography during thrombolysis with tissue plasminogen activator of a thrombosed prosthetic mitral valve. J Am Soc Echocardiogr 1992; 5: 153-8.
17. Luluaga IT, Carrera D, D-Oliveira J, et al. Successful thrombolytic therapy after acute tricuspid-valve obstruction (Letter). Lancet 1971; 1: 1067-8.
18. Graver LM, Gelber PM, Tyras DH. The risks and benefits of thrombolytic therapy in acute aortic and mitral prosthetic valve dysfunction: report of a case and review of the literature. Ann Thorac Surg 1988; 46: 85-8.
19. Ludwig H. Thrombolytic therapy in pregnancy. Experimental and clinical studies. Thrombosis Diathesis Haemorrhagica 1972; 47(Suppl): 243-54.
20. Delctos GL, Davila F. Thrombolytic therapy for pulmonary embolism in pregnancy. A case report. Am J Obstet Gynecol 1986; 155: 375-6.
21. Flossdorf T, Breulmann M, Hopf HB. Successful treatment of massive pulmonary embolism with recombinant tissue type plasminogen activator (rt-PA) in a pregnant woman with intact gravidity and preterm labour. Intensive Care Med 1990; 16: 454-6.
22. Petit H, Michel JM, Thiranos JC, de Geeter B, Kieny R. Pulmonary valve thrombosis: echocardiographic diagnosis and thrombolytic therapy. CV World Report 1989; 2: 96-100.
23. Azzano O, French P, Robin J, et al. Thrombolytic therapy with recombinant tissue type plasminogen activator (rt-PA) for thrombosis of a tricuspid valve prosthesis during pregnancy. (French) Arch Mal Coeur Vaiss 1995; 88: 267-70.
24. Hanania G, Thomas D, Michel PL, et al. Pregnancy in patients with heart valve prostheses. A French retrospective cooperative study (155 cases). (French) Arch Mal Coeur Vaiss 1994; 87: 429-37.
25. Moisson P, Cornier E, Rozenstajn L, Catinat J. Thrombosis of a metral valve prosthesis in a pregnant woman. Treatment with streptokinase. (French) Coeur et Medecine Internet 1979; 18: 425-32.
26. Jimenez M, Vergnes C, Brottier L, et al. Reccurent thrombosis on aortic valve prosthesis during pregnancy. Results of treatment with urokinase. (French) J Mal Vasc 1988; 12: 46-9.
27. Witchitz S, Veyrat C, Moisson P, Scheinman N, Rozenstajn L. Fibrinolytic treatment of thrombus on prosthetic heart valves. Br Heart J 1980; 44: 545-54.
28. Tissot H, Vergnes C, Rougier P, Bricaud H, Dallay D. Therapeutic thrombolysis using urokinase steptokinase for the recurrent thrombosis in two valve prostheses for the aortic and mitral valve in pregnancy. (French) J Gynecol Obstet Biol Reprod 1991; 20: 1093-6.
29. Di Roio C, Perrot D, Védrinne JM, Méllier G, Robin J, Matin J. Therapeutic thrombolysis using recombinant tissue type plasminogen activator (rt-PA) for a recurrent thrombosis of a tricuspid valve prosthesis during pregnancy. (French) Ann Fr Anesth Reanim 1996; 15: 666-8.